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ORIGINAL ARTICLE / ÖZGÜN ARAŞTIRMA
The relationship between neutrophil to lymphocyte ratio and SYNTAX score in patients 
with ST-segment elevation myocardial infarction
ST-segment yükselmeli miyokard infarktüsünde nötrofil lenfosit oranı ve syntax skoru 
arasındaki ilişki
Halit Acet1, Faruk Ertaş1, Mehmet Zihni Bilik1, Fethullah Kayan1, Mehmet Ata Akıl1, Mesut Aydın1, Abdurrahman 
Akyüz2, Murat Yüksel1, Hilal Ayçiçek1, Mehmet Özbek1, Mustafa Oylumlu1, Abdulkadir Yıldız1, Sait Alan1 
ÖZET
Amaç: Biz bu çalışmada STEMİ hastalarında nötrofil len-
fosit oranı (NLO) ve Syntax skoru (SS) ile değerlendiri-
len koroner aterosklerozun şiddeti arasındaki ilişkiyi ST 
yükselmeli miyokard infarktüsü (STEMİ)’ünde değerlen-
dirmeyi amaçladık.
Yöntemler:  Dışlama  kriterleri  sonrası  primer  perkütan 
koroner girişim uygulanan geriye dönük olarak toplamda 
291 STEMI hastası çalışmaya alındı. (216 erkek,75 ka-
dın, ortalama yaş 61,6±14,0 yıl). Toplam ve diferensiyel 
lökosit sayımı ve diğer biyokimyasal belirteçler hasta ka-
bulünde alındı. Hastalar SS göre üç tertile ayrıldı. Majör 
istenmeyen kardiyak olaylar (MİKO) için izleme hastane-
de yatış döneminde yapıldı 
Bulgular:  SSyüksek  grup,  lökosit  (p=0,009),  nötrofil 
(p=0,008), NLO (p=0,048), zirve troponin (p<0,001), zir-
ve CK-MB (p=0,001) laktat dehidrogenaz (p=0,005), as-
partat aminotransferaz (p=0,004) değerleri SSdüşük ve 
SSorta grupları ile karşılaştırıldığında anlamlı derecede 
yüksek  saptandı.  SS  artığında,  Sol  ventrikül  ejeksiyon 
fraksiyonunda düşme (p<0,001) ve sol ventrikül sistolik 
çapında (p=0,007) artış izlendi. Hastane içi ölüm oranı 
ve MİKO diğer gruplara (p<0,001 her ikisi için) oranla SS 
yüksek grubunda daha fazlaydı.
Sonuçlar:  Çalışmamızda  NLO  artışı  ile  SS  artışı  ara-
sında anlamlı bir ilişki bulduk. Buna ek olarak, SS artışı 
ile hastane içi MİKO ve hastane içi ölüm arsındaki artan 
önemli bir ilişki saptadık. İleriye dönük çalışmalarda NLO 
ve SS birlikte STEMİ hastalarının sınıflandırılmasında risk 
tahmininde değerlendirilebilir.
Anahtar kelimeler: Nötrofil lenfosit oranı, Syntax skoru, 
STEMI
ABSTRACT
Objective: We aimed to assess relationship between the 
severity of coronary atherosclerosis assessed by SYN-
TAX score (SS) and neutrophil to lymphocyte ratio (NLR) 
in patients with ST elevation myocardial infarction (STE-
MI.
Methods: After accounting for exclusion criteria, a total 
of 291 patient with STEMI in whom primary percutaneous 
coronary intervention was performed were retrospective-
ly included (216 male, 75 female; mean age 61.6+14.0 
years). Total and differential leukocyte counts and other 
biochemical markers were measured at admission. Pa-
tients were categorized into tertiles on the basis of SS. 
Monitoring  for  major  adverse  cardiac  events  (MACEs) 
was performed during the in hospital follow-up period.
Results: The SS high group leukocyte (p=0.009), neutro-
phil (p=0.008), NLR (p=0.048), peak troponin (p<0.001), 
peak CK-MB (p=0.001) lactate dehydrogenase (p=0.005), 
aspartate aminotransferase (p=0.004) values were signif-
icantly higher compared with SSlow and SSmid groups. 
SS was increased, left ventricular ejection fraction was 
decrease (p<0.001) and left ventricular systolic diameter 
was increased (p=0.007). The in-hospital death rate and 
MACEs were greater in the high SS group than in the 
other groups (p<0.001 both of). 
Conclusion: We found that high NLR was significantly 
and correlated increased with SS. In addition, high SS 
were  significantly  associated  with  increased  in-hospital 
MACE and in-hospital death. Further prospective studies 
assessing the predictive role of both SS and NLR in con-
junction for risk stratification might improve risk predic-
tion in patients with STEMI. J Clin Exp Invest 2014; 5 (2): 
211-218
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INTRODUCTION
Coronary artery disease (CAD) and acute myocar-
dial infarction (MI) are a major cause of death and 
morbidity  worldwide. Atherosclerosis  is  the  major 
cause of cardiovascular disease (CVD) [1-3]. Mul-
tiple pathophysiological factors influence this ath-
erosclerotic process and one of the most important 
factors is inflammation [4]. Inflammation plays a sig-
nificant role in initiating atherosclerosis and facilitat-
ing its progression [5].
White blood cell (WBC) count and the neutro-
phil and lymphocyte have been investigated as in-
flammatory markers to predict cardiovascular out-
comes in patients with CAD [6,7] The neutrophil to 
lymphocyte ratio (NLR) is calculated from the WBC-
c and is a novel prognostic marker in patients with 
CVD [8,9]. High NLR was reported to be associated 
with increased cardiac mortality in clinically stable 
patients with CAD [6-7]. Increased NLR was also re-
ported to be associated with the presence and long-
term mortality of ST elevation myocardial infarction 
(STEMI) [10].
The SYNTAX score (SS) is a comprehensive 
anatomic scoring system based on the coronary an-
giogram. The SS quantifies the properties of lesion 
including  complexity,  morphology,  and  location  in 
coronary tree and predicts outcome after percuta-
neous coronary intervention (PCI) in patients with 
CAD who are undergoing revascularization [11-13]. 
Also, the SS reflects the pattern of atheroma and 
the technical difficulty of PCI [12]. It is able to aid 
revascularization  decisions  and  predicts  mortality 
and morbidity in patients with CAD [11,12]. The rela-
tionship between NLR and STEMI has been shown 
in several studies, but there is little data available 
about the association of NLR levels with SS. In this 
study, we aimed to evaluate relationship between 
the severity of coronary atherosclerosis assessed 
by SS and NLR in patients with STEMI.
METHODS
Study population
A total of 600 patients that retrospective presented 
with  STEMIs  and  underwent  primary  PCIs  within 
12 hours of symptom onset between January 2012 
and March 2013 were included in the study. STEMI 
was defined based criteria created by the American 
College of Cardiology and the European Society of 
Cardiology [14]: an increase in troponin I >1 ng/mL; 
a new ST elevation as measured from the J-point in 
2 or more contiguous leads with leads V1, V2, and 
V3 measuring at least 0.2 mV or at least 0.1 mV in 
the remaining leads; during the first 12 hours after 
symptom onset.
Exclusion criteria from the study were patients 
with  severe  liver  disease,  autoimmune  diseases, 
cancer,  hematological  disorders,  severe  valvular 
disease, inflammatory or infectious diseases, and a 
history of bleeding diathesis. Patients on the follow-
ing medications were excluded from the study: cor-
ticosteroids, cytotoxic drugs, thrombolytic therapy, 
glycoprotein IIb/IIIa inhibitors, diuretics, if during the 
study the patient was not treated with primary PCI, 
did not follow-up for blood work, and had poor echo-
cardiographic windows, then they were also elimi-
nated from the investigation. After accounting for all 
of these exclusion criteria, a total of 291 patients 
remained in study sample. All patients received a 
complete physical examination, assessment of cor-
onary risk factors, and medical histories and pre-
senting clinical symptoms were also recorded. Pa-
tients were evaluated for heart failure prognosis ac-
cording to Killip clinical examination guidelines [15].
Monitoring  for  major  adverse  cardiac  events 
(MACEs)  was  performed  during  the  in  hospital 
follow-up period. Examples of MACEs were cardio-
genic  shock,  new  advanced  heart  failure,  pulmo-
nary edema, complete atrioventricular block (AVB) 
requiring a temporary pacemaker, severe ventricu-
lar arrhythmia and in-hospital mortality during the 
post-PCI  follow-up  period.  An  in-hospital  mortal-
ity was only considered a MACE if the death was 
due to myocardial infarction, cardiac arrest, or due 
to some other cardiac-related cause. Cardiogenic 
shock was defined as marked and persistent hypo-
tension lasting more than 30 minutes with a systolic 
arterial pressure less than 80 mmHg with signs of 
hypoperfusion  due  to  left  ventricular  dysfunction, 
right  ventricular  infarction,  or  cardiac  mechanical 
complications.  New-onset  advanced  heart  failure 
was  diagnosed  if  the  patient  qualified  for  a  New 
York Heart Association functional classification of III 
or greater. In order for a severe ventricular arrhyth-
mia to be considered a MACE, it needed to occur 
within 48 hours of admission and the rhythm must 
have been ventricular fibrillation, ventricular tachy-
cardia, or asystole.
Blood work and echocardiography
Venous  blood  samples  were  collected  when  the 
patient initially presented to the emergency depart-
ment or intensive coronary care unit (ICCU) before 
primary PCI. Hematologic indices were measured 
by an automated hematology analyzer system (Ab-Acet et al. Neutrophil to lymphocyte ratio and SYNTAX score in myocardial infarction 213
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bott Cell-Dyn 3700; Abbott Laboratory, Abbott Park, 
Illinois). Absolute cell counts were utilized to perform 
subsequent analyses. Baseline NLR was measured 
by dividing the neutrophil count by the lymphocyte 
count.  Total  cholesterol,  high-density  lipoprotein 
(HDL), low-density lipoprotein (LDL), triglycerides, 
glucose and creatinine levels were measured with 
the Abbott Architect C16000 autoanalyzer (Abbott 
Laboratory). Creatinine kinase-MB (CK-MB) levels 
were measured with a Beckman Access analyzer 
(U.S.A). Troponin  I  levels  were  measured  with  a 
Beckman Image 800 analyzer (U.S.A). 
Transthoracic two-dimensional echocardiogra-
phy was performed upon admission to the ICCU to 
determine left ventricular ejection fraction (LVEF), 
left ventricular systolic diameter (LVSD), left ventric-
ular diastolic diameter (LVDD), and left atrial diam-
eter (Vivid S6, GE Medical Systems, USA).
Syntax Score and Angiographic Analysis
All patients underwent selective coronary angiogra-
phy using the Judkins technique. Coronary lesions 
leading to ≥50% diameter stenosis in vessels ≥1.5 
mm was scored separately and added together to 
provide the cumulative SS which was prospectively 
calculated using the SS algorithm on the baseline 
diagnostic angiogram [16]. Two experienced inter-
ventional cardiologists analyzed the SS; the opinion 
of a third analyst was obtained and the final judg-
ment was made by consensus in cases of disagree-
ment. The final score was calculated from the indi-
vidual lesion scores by analysis who were blinded to 
procedural data and clinical outcome. The Gensini 
scoring system was used to determine the severity 
of CAD [17].
Statistical analysis
All analyses were performed with SPSS for Win-
dows  version  18.0  (SPSS  Inc.  Chicago,  Illinois, 
USA).  Continuous  variables  were  expressed  as 
the mean plus minus standard deviation (SD), and 
categorical variables were expressed as percent-
ages.  The  two  sample  Kolmogorov-Smirnov  test 
assessed  whether  continuous  variables  followed 
a  normal  distribution.  Comparisons  between  cat-
egorical variables between the SS groups were per-
formed using the χ2 or Fischer’s exact test. Analysis 
of variance (ANOVA) and Kruskal Wallis test were 
used in the analysis of continuous variables. A strat-
ified  analysis  of  clinical  and  laboratory  variables 
was performed according to the tertiles of the SS. 
The correlation between SS and clinical, laboratory 
parameters was assessed by the Pearson correla-
tion test. Statistical significance was defined as a 
p-value less than 0.05.
The study protocol was reviewed and approved 
by  the  Ethics  Committee  in  accordance  with  the 
Declaration of Helsinki.
RESULTS
The SS classified as tertiles are SSlow <12 (n=84), 
SSmid  >12  and  <22  (n=102),  and  SShigh  ≥22 
(n=105).  The  baseline  characteristics  of  the  3 
groups are summarized in Table 1. Mean age of 
SShigh group was higher than SSlow and SSmid 
groups  (P=0.003  for  all).  Frequency  of  HT,  DM 
smoking,  hyperlipidemia  positive  family  history 
and previous medical history were similar between 
the groups. Killip class III-IV were more common 
in SShigh group patients (p<0.001 for all). Admis-
sion heart rate was high in SShigh group patients 
(p=0.021  for  all).  Initial  laboratory  findings  of  pa-
tient groups were compared in Table 2. The SShigh 
group WBC count (p=0.009 for all), neutrophil count 
(p=0.008 for all), NLR (p=0.048 for all), peak tro-
ponin levels (p<0.001 for all), peak CK-MB levels 
(p=0.001 for all), lactate dehydrogenase (p=0.005 
for all), aspartate aminotransferase (p=0.004 for all) 
values were significantly higher compared with SS-
low and SSmid groups. Echocardiographic and an-
giographic characteristics are listed in Table 3. SS 
was  increased,  LVEF  was  signifficantly  decrease 
(p<0.001 for all) and LVSD was increased (p=0.007 
for all). The Gensini score was higher in the high SS 
group as compared to the other groups (p<0.001). 
The in-hospital adverse outcomes are listed in Table 
4. The in-hospital death rate was greater in the high 
SS group than in the other groups (p<0.001). MAC-
Es were more frequent in the high SS group than 
in the other groups (p<0.001). Similarly, in hospital 
advanced pulmonary edeme (p=0.032), in-hospital 
cardiogenic shock (p=0.008), severe ventricular ar-
rhythmia (p=0.002), cardiopulmonary resuscitations 
(p<0.001), were higher in the high SS group than 
in  the  other  groups  patients.  Pearson’s  correla-
tion analysis revealed significant associations be-
tween a high SS and age (r=0.206, p<0.001), NLR 
(r=0.148, p=0.012) (Fig. 1), peak troponin (r=0.248, 
p<0.001), peak CK-MB (r=0.200, p=0.001), lactate 
dehydrogenase (r=0.221, p<0.001), aspartate ami-
notransferase (r=0.179, p=0.003), killip on admis-
sion (r=0.245, p<0.001), number of coronary arteries 
narrowed (r=0.489, p<0.001), In-hospital mortality 
(r=0.246, p=0.001) and In-hospital MACE (r=0.258, 
p<0.001), Gensini score (r=0.661, p<0.001) (Table 
5).Acet et al. Neutrophil to lymphocyte ratio and SYNTAX score in myocardial infarction 214
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Table 1. Demografic Characteristics of Patients in Syntax Score Groups
Variables
SS Low
n=84
SS Mid
n=102
SS High
n=105 p value
Age, years 58.33±12.57 60.75±15.62 65.08±12.84 0.003*
Sex, male, n (%) 66 (31) 76 (35) 74(34) 0.448
Previous history
Hypertension , n (%) 34 (31) 31 (28) 44 (41) 0.180
Diabetes mellitus, n (%) 20 (29) 26 (38) 23 (33) 0.832
Smoking, n (%) 58 (35) 58 (35) 49 (30) 0.090
Hyperlipidemia, n (%) 3 (21) 5 (36) 6 (43) 0.790
Family history of CAD, n (%) 16 (28) 20 (34) 22 (38) 0.943
Cerebrovascular event, n (%) 5 (33) 3 (20) 7 (47) 0.444
History of PCI, n % 3 (23) 3 (23) 7 (54) 0.386
History of CAD, n (%) 2 (15) 2 (15) 9 (70) 0.039
Previous medication
Preadmission aspirin use, n (%) 66 (30) 71 (33) 79 (37) 0.364
Preadmission clopidogrel use, n (%) 51 (35) 48 (33) 46 (32) 0.055
Beta blocker, n (%) 7 (24) 9 (31) 13 (45) 0.583
ACE inhibitors, n (%) 8 (25) 11 (34) 13 (41) 0.820
Statin, n (%) 6 (27) 6 (27) 10 (46) 0.603
Preadmission enoxaparine use, n (%) 72 (27) 96 (37) 95 (36) 0.154
Killip on admission
I-II 83 (99) 99 (97) 90 (86)
<0.001
III-IV 1 (1) 3 (3) 15 (14)
Admission SBP (mmHg) 126.08±18.91 129.74±24.27 125.19±26.25 0.350
Admission heart rate (bpm) 79.30±14.79 83.83±16.87 86.09±18.06 0.021
*Kruskal Wallis test; Other statics ANOVA test and χ 2 test; Syntax score, SS; PCI,Percutaneous coronary intervention 
CAD, Coronary artery disease
Table 2. A Comparison of Initial Laboratory Values of Patients in Syntax Score Groups
Laboratory Findings
SS Low
n=84
SS Mid
n =102
SS High
n=105 p value
WBC, K/uL 12.65±4.80 13.65±4.90 14.51±5.44 0.009*
RBC, M/uL 4.83±0.48 4.87±0.57 4.89±0.56 0.806
Hemoglobin, g/dL 13.87±1.50 14.13±1.67 13.94±1.60 0.498
RDW, % 15.75±1.39 16.20±1.71 16.01±1.63 0.166
PDW, NULL 17.87±1.27 17.85±1.01 17.92±1.20 0.542
Platelet count, K/uL 242.29±67.29 257.31±69.66 248.63±59.33 0.213
Lymphocyte count, NULL 1.92±0.97 1.99±1.05 1.96±1.48 0.923
Monocyte count, NULL 0.63±0.25 0.69±0.33 0.67±0.33 0.423
Basophil count, NULL  0.07±0.04 0.08±0.07 0.07±0.05 0.309
Neutrophil count, NULL  9.93±4.37 10.91±4.76 11.82±5.08 0.008*
NLR 6.40±3.66 6.92±4.16 8.20±5.60 0.048*
PLR 153.35±76.47 165.62±99.30 168.13±97.96 0.525
Glucose on admission, mg/dL 161.69±71.15 167.20±75.96 179.84±95.39 0.291
Creatinine on admission, mg/dL 0.86±0.28 0.89±0.21 0.94±0.53 0.320
Lactate dehydrogenase U/L 328.64±156.58 389.06±213.69 461.27±281.40 0.005*
Aspartate aminotransferase U/L 83.24±84.16 105.40±84.49 146.03±158.05 0.004*
Alanin aminotransferaz U/L 35.13±27.82 47.34±61.86 51.37±77.52 0.186
Peak Troponin I, ng/mL 40.34±36.87 62.11±34.15 68.48±35.46 <0.001*Acet et al. Neutrophil to lymphocyte ratio and SYNTAX score in myocardial infarction 215
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(Önceki sayfadan devam)
Peak CK-MB mass, ng/mL 144.27±114.14 207.61±103.29 210.48±109.46 0.001*
Total cholesterol, mg/dL 175.38±33.43 181.18±39.04 172.34±42.32 0.253
LDL, mg/dL 109.60±28.97 115.55±30.64 114.44±33.18 0.398
HDL, mg/dL 33.35±7.72 35.79±11.37 35.06±9.81 0.236
Triglycerides, mg/dL 163.02±81.15 150.34±99.10 141.47±97.14 0.291
Values are mean ±SD or n (%),*Kruskal Wallis test; Other statics ANOVA test; WBC, White blood cell count; RBC Red 
blood cell count; RDW, Red cell distribution width; PDW, Platelet distrubition width; NLR, Neutrophyl/lymphocyte ratio 
PLR, Platelet/lymphocyte ratio LDL, low-density lipoprotein; HDL, high-density lipoprotein; CK, Creatin kinase;
Table 3. A Comparison of Echocardiographic, Angiographic Findings of Patients in Syntax Score Groups
Variables SS Low
n=84
SS Mid
n =102
SS High
n=105
p value
STEMI location
Anterior, n (%) 17 (20) 57 (56) 60 (46)
<0.001
Nonanterior, n (%) 67 (80) 45 (44) 45 (549
Duration of chest pain (hour) 5.41±2.99 6.00±3.36 5.56±3.51 0.443
Admission LVEF (%) 50.07±7.67 43.11±8.96 38.63±9.60 <0.001*
Left ventricular diastolic diameter (mm) 45.96±5.17 46.43±5.35 46.75±5.60 0.644
Left ventricular systolic diameter (mm) 32.12±5.73 33.48±5.87 35.04±6.50 0.007*
Left atrial diameter (mm) 37.09±5.33 35.35±5.06 36.53±5.25 0.028
Culprit lesion
LAD, n (%) 20 (24) 60 (59) 59 (56)
<0.001 RCA, n (%) 49 (58) 29 (28) 30 (29)
CX, n (%) 15 (18) 13 (13) 16 (15)
Number of coronary arteries narrowed
1 vessel, n (%) 62 (74) 51 (50) 14 (13)
<0.001
>1 vessel n, (%) 22 (26) 51 (50) 91 (87)
Gensini score 35.21±14.63 57.98±21.23 59.81±29.21 <0.001*
Syntax score 7.51±2.80 16.66±2.82 31.19±9.80 <0.001*
*Kruskal Wallis test; Other statics ANOVA test and χ 2 test; Syntax score, SS LVEF, left ventricular ejection fraction; 
LAD, left descendan coronary artery; RCA, right coronary artery; CX, circumflex coronary artery
Table 4. A Comparison of İn-hospital Major Adverse Cardiovascular Events of Patients in Syntax Score Groups
Variables SS Low
n=84
SS Mid
n =102
SS High
n=105
p value
In hospital MACEs, n (%) 9(14) 17(27) 38(59) <0.001
Advanced heart failure, n (%) 3(18) 7(41) 7(41) 0.574
Advanced pulmonary edema, n (%) 0(0) 4(33) 8(67) 0.032
Cardiogenic shock, n (%) 2(10) 5(24) 14(66) 0.008
Complete AVB requiring transient pacemaker, n (%) 3(20) 4(27) 8(53) 0.358
Serious ventricular arrhythmia, n (%) 0(0) 4(25) 12(75) 0.002
In-hospital mortality, n (%) 1(4) 6(21) 21(75) <0.001
Cardiopulmonary resusitation , n (%) 1(3) 10(32) 20(64) <0.001
Time of hospital stay (days) 4.29±2.86 5.29±5.55 5.95±5.06 0.059
Statics ANOVA test and χ 2 test; MACE, major advers cardiovascular event; AVB, atrioventricular block,Acet et al. Neutrophil to lymphocyte ratio and SYNTAX score in myocardial infarction 216
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Table 5. Pearson Correlations of Patients in Syntax Score
r p value
Age 0.206 <0.001
Admission heart rate (bpm) 0.147 0.012
Admission LVEF (%) -0.392 <0.001
Left ventricular systolic diameter (mm) 0.171 0.006
Killip classification on presentation 0.245 <0.001
WBC K/uL 0.112 0.058
Neutrophil count, NULL 0.112 0.038
Peak Troponin I, ng/mL 0.248 <0.001
Peak CK-MB mass, ng/mL 0.200 0.001
Lactate dehydrogenase U/L 0.221 <0.001
Aspartate aminotransferase U/L 0.179 0.003
NLR 0.148 0.012
Number of coronary arteries narrowed 0.489 <0.001
In-hospital mortality 0.246 0.001
In-hospital MACE 0.258 <0.001
Gensini score 0.661 <0.001
WBC, White blood cell count;LVEF, Left ventricular ejec-
tion fraction
NLR, Neutrophyl/lymphocyte ratio MACE, major advers 
cardiovascular event
DISCUSSION
We showed that NLR was significantly associated 
with SS in patients STEMI. Also, we demonstrated 
that  on  admission  heart  rate,  LVEF,  LVSD,  killip 
class, peak troponin, peak CK-MB, lactate dehydro-
genase,  aspartate  aminotransferase,  multivessel 
disease, in-hospital mortality and in-hospital MACE 
were significantly associated with SS in STEMI pa-
tients.  Moreover  SS  was  signifficantly  correlated 
with  NLR  on  admission  heart  rate,  LVEF,  LVSD, 
killip  class,  peak  troponin,  peak  CK-MB,  lactate 
dehydrogenase, aspartate aminotransferase, multi-
vessel disease, in-hospital mortality and in-hospital 
MACEs. Atherogenesis  is  an  active  inflammatory 
process [5] with vitally acting leukocytes [18]. Neu-
trophils play role either in adaptive infarct healing 
or in leukocyte platelet aggregate formation and in 
reperfusion injury in the setting of acute coronary 
syndromes (ACS) [19,20]. Several previous studies 
have assesed the relation of total and differential 
WBC count and presence and prognosis of CAD. 
White blood cell count, neutrophil count, and NLR 
were reported as an independent prognostic predic-
tor both in acute MI [21,22] and in stable CAD [7]. 
Lymphocytes also play a important role in modulat-
ing  the  inflammatory  response  in  atherosclerotic 
process [23] and comparative lymphopenia in MI 
was postulated as a stress response mediated by 
increased endogenous cortisol [24,25].
Recent studies have shown that high neutro-
phil counts are associated with poorer angiographic 
outcomes, larger infarct sizes, and worse prognosis 
in STEMI patients [10,22,26]. Several studies have 
demonstrated that NLR is a marker of CVD prog-
nosis [27]. Previous studies centre on NLR and its 
association with adverse outcomes in patients with 
ACSs [28]. Arbel et al. found that increased NLR was 
associated with increased severity of CAD, thereby 
providing additive predictive value to conventional 
risk factors and commonly used biomarkers e.g. C-
Reactive Protein and total WBC count [29]. Polat 
et al. show that increased NLR was signifficantly 
associated with increased severity of rheumatic mi-
tral valvular disease [30]. Yıldız et al. show that in-
creased NLR was signifficantly associated with ven-
tricular premature contraction existence [31]. Acet 
et al. show that increased NLR was indepently and 
signifficantly associated with severity and duration of 
atrial fibrillation [9]. Kaya et al. show that increased 
NLR was signifficantly associated with severity of 
stable CAD with gensini score [8]. Yıldız et al dem-
onstrate that NLR was signifficantly associated with 
the coronary no-reflow phenomenon in STEMI pa-
tients [32]. Oylumlu et al. show that NLR was new 
inflammatory markers in pre-eclampsia [33]. Yıldız 
et al. show that detected a significant association 
between the NLR and low funtional capacity, both 
of which has predictive and prognostic value in pa-
tients with heart failure [34]. Yıldız et al. show that 
myocardial bridge is associated with elevated NLR, 
which is used to assess inflammatory status of the 
body [35]. Çil et al. show that there was no associa-
tion between NLR and coronary collateral circula-
tion with diagnosis of CAD and detected significant 
stenosis or occlusion at least one of the coronary 
arteries [36]. Increase in the severity of CAD with 
respect to SS was associated with increased neu-
trophils and finally with increased NLR in our study. 
Similar to the current study, a relationship between 
NLR and severity of CAD was reported in patients 
with stable CAD [6,7]. However, a similar indepen-
dent relationship was investigated a little in STEMI. 
To our knowledge, only one study by Şahin et al. 
has investigated the relationship between NLR and Acet et al. Neutrophil to lymphocyte ratio and SYNTAX score in myocardial infarction 217
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SS [37]. They investigated the relationship between 
NLR and SS in STEMI patients. They showed that 
NLR was significantly increased with SS. Similarly, 
we have shown that NLR is significantly associat-
ed with SS. Multiple ACS studies now support the 
use of NLR as an admission biomarker, which can 
be used to determine prognosis [38]. NLR can be 
readily calculated at point of care, thereby facilitat-
ing short and long-term risk prediction for STEMI 
patients, even prior to revascularization. 
Conclusion: We found that high NLR was signif-
icantly and correlated increased with SS in patients 
with STEMI. In addition, we found that high SS were 
significantly  associated  with  increased  in-hospital 
MACE  and  in-hospital  death.  Further  prospective 
studies assessing the predictive role of both SS and 
NLR in conjunction for risk stratification might im-
prove risk prediction in patients with STEMI. 
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